nodes	percent_of_prediction	percent_of_DWPC	metapath
Rabeprazole—CYP1A1—Clonidine—glaucoma	0.0607	0.0967	CbGbCtD
Rabeprazole—CYP2D6—Carteolol—glaucoma	0.0603	0.0962	CbGbCtD
Rabeprazole—CYP1A2—Betaxolol—glaucoma	0.0495	0.0788	CbGbCtD
Rabeprazole—CYP2D6—Betaxolol—glaucoma	0.0408	0.065	CbGbCtD
Rabeprazole—CYP2C19—Methazolamide—glaucoma	0.0406	0.0648	CbGbCtD
Rabeprazole—CYP2C9—Diclofenamide—glaucoma	0.0392	0.0625	CbGbCtD
Rabeprazole—CYP2C9—Dorzolamide—glaucoma	0.0379	0.0604	CbGbCtD
Rabeprazole—CYP2C19—Timolol—glaucoma	0.0346	0.0551	CbGbCtD
Rabeprazole—CYP2C9—Methazolamide—glaucoma	0.0338	0.0538	CbGbCtD
Rabeprazole—CYP2D6—Methazolamide—glaucoma	0.0309	0.0492	CbGbCtD
Rabeprazole—CYP3A4—Pilocarpine—glaucoma	0.0291	0.0463	CbGbCtD
Rabeprazole—CYP1A2—Clonidine—glaucoma	0.0271	0.0432	CbGbCtD
Rabeprazole—CYP2D6—Timolol—glaucoma	0.0263	0.0419	CbGbCtD
Rabeprazole—CYP3A4—Brinzolamide—glaucoma	0.0228	0.0364	CbGbCtD
Rabeprazole—CYP2D6—Clonidine—glaucoma	0.0223	0.0356	CbGbCtD
Rabeprazole—CYP3A4—Dorzolamide—glaucoma	0.022	0.0351	CbGbCtD
Rabeprazole—CYP3A4—Methazolamide—glaucoma	0.0196	0.0313	CbGbCtD
Rabeprazole—CYP3A4—Acetazolamide—glaucoma	0.0157	0.025	CbGbCtD
Rabeprazole—CYP3A4—Clonidine—glaucoma	0.0142	0.0226	CbGbCtD
Rabeprazole—Omeprazole—CYP1B1—glaucoma	0.00226	0.522	CrCbGaD
Rabeprazole—Lansoprazole—CYP1B1—glaucoma	0.00206	0.478	CrCbGaD
Rabeprazole—CYP3A4—Aflatoxin B1 metabolism—GSTM1—glaucoma	0.000234	0.0123	CbGpPWpGaD
Rabeprazole—CYP1A2—Estrogen Receptor Pathway—CYP1B1—glaucoma	0.000231	0.0122	CbGpPWpGaD
Rabeprazole—CYP1A1—Estrogen metabolism—GSTM1—glaucoma	0.000224	0.0118	CbGpPWpGaD
Rabeprazole—ATP4A—Transmembrane transport of small molecules—SLC6A13—glaucoma	0.00021	0.011	CbGpPWpGaD
Rabeprazole—CYP2C19—Tamoxifen metabolism—CYP1B1—glaucoma	0.000202	0.0106	CbGpPWpGaD
Rabeprazole—CYP1A1—Melatonin metabolism and effects—CYP1B1—glaucoma	0.000191	0.01	CbGpPWpGaD
Rabeprazole—CYP2D6—Tamoxifen metabolism—CYP1B1—glaucoma	0.000186	0.00979	CbGpPWpGaD
Rabeprazole—CYP2C9—Tamoxifen metabolism—CYP1B1—glaucoma	0.000185	0.00971	CbGpPWpGaD
Rabeprazole—ABCG2—Fluoropyrimidine Activity—MTHFR—glaucoma	0.00018	0.00946	CbGpPWpGaD
Rabeprazole—CYP1A2—Estrogen metabolism—CYP1B1—glaucoma	0.000178	0.00938	CbGpPWpGaD
Rabeprazole—ATP4B—Transmembrane transport of small molecules—SLC6A1—glaucoma	0.000172	0.00905	CbGpPWpGaD
Rabeprazole—CYP1A1—Oxidative Stress—SOD1—glaucoma	0.000166	0.00872	CbGpPWpGaD
Rabeprazole—CYP1A2—Tamoxifen metabolism—CYP1B1—glaucoma	0.000158	0.00829	CbGpPWpGaD
Rabeprazole—CYP2C19—Melatonin metabolism and effects—CYP1B1—glaucoma	0.000156	0.00822	CbGpPWpGaD
Rabeprazole—CYP1A1—Melatonin metabolism and effects—EDN1—glaucoma	0.000155	0.00813	CbGpPWpGaD
Rabeprazole—ATP4A—Transmembrane transport of small molecules—SLC6A1—glaucoma	0.000153	0.00806	CbGpPWpGaD
Rabeprazole—Hyperglycaemia—Timolol—glaucoma	0.000148	0.000425	CcSEcCtD
Rabeprazole—Agitation—Clonidine—glaucoma	0.000148	0.000424	CcSEcCtD
Rabeprazole—Paraesthesia—Pilocarpine—glaucoma	0.000148	0.000423	CcSEcCtD
Rabeprazole—Asthenia—Bimatoprost—glaucoma	0.000148	0.000423	CcSEcCtD
Rabeprazole—Angioedema—Clonidine—glaucoma	0.000147	0.000421	CcSEcCtD
Rabeprazole—Dyspnoea—Pilocarpine—glaucoma	0.000147	0.00042	CcSEcCtD
Rabeprazole—Pain—Brinzolamide—glaucoma	0.000146	0.000419	CcSEcCtD
Rabeprazole—Somnolence—Pilocarpine—glaucoma	0.000146	0.000419	CcSEcCtD
Rabeprazole—Angiopathy—Betaxolol—glaucoma	0.000146	0.000419	CcSEcCtD
Rabeprazole—Pruritus—Bimatoprost—glaucoma	0.000146	0.000417	CcSEcCtD
Rabeprazole—Diarrhoea—Apraclonidine—glaucoma	0.000145	0.000416	CcSEcCtD
Rabeprazole—Malaise—Clonidine—glaucoma	0.000145	0.000416	CcSEcCtD
Rabeprazole—Dyspepsia—Pilocarpine—glaucoma	0.000145	0.000415	CcSEcCtD
Rabeprazole—Chills—Betaxolol—glaucoma	0.000145	0.000414	CcSEcCtD
Rabeprazole—Syncope—Clonidine—glaucoma	0.000144	0.000414	CcSEcCtD
Rabeprazole—Arrhythmia—Betaxolol—glaucoma	0.000144	0.000412	CcSEcCtD
Rabeprazole—CYP2D6—Melatonin metabolism and effects—CYP1B1—glaucoma	0.000144	0.00756	CbGpPWpGaD
Rabeprazole—Feeling abnormal—Dorzolamide—glaucoma	0.000144	0.000411	CcSEcCtD
Rabeprazole—Decreased appetite—Pilocarpine—glaucoma	0.000143	0.00041	CcSEcCtD
Rabeprazole—Feeling abnormal—Travoprost—glaucoma	0.000143	0.000409	CcSEcCtD
Rabeprazole—CYP1A2—Estrogen metabolism—GSTM1—glaucoma	0.000143	0.0075	CbGpPWpGaD
Rabeprazole—Conjunctivitis—Timolol—glaucoma	0.000142	0.000408	CcSEcCtD
Rabeprazole—Gastrointestinal pain—Dorzolamide—glaucoma	0.000142	0.000408	CcSEcCtD
Rabeprazole—Alopecia—Betaxolol—glaucoma	0.000142	0.000408	CcSEcCtD
Rabeprazole—Palpitations—Clonidine—glaucoma	0.000142	0.000408	CcSEcCtD
Rabeprazole—Gastrointestinal pain—Travoprost—glaucoma	0.000142	0.000406	CcSEcCtD
Rabeprazole—Loss of consciousness—Clonidine—glaucoma	0.000142	0.000405	CcSEcCtD
Rabeprazole—Feeling abnormal—Brinzolamide—glaucoma	0.000141	0.000404	CcSEcCtD
Rabeprazole—Constipation—Pilocarpine—glaucoma	0.000141	0.000403	CcSEcCtD
Rabeprazole—Pain—Pilocarpine—glaucoma	0.000141	0.000403	CcSEcCtD
Rabeprazole—Cough—Clonidine—glaucoma	0.000141	0.000403	CcSEcCtD
Rabeprazole—Sweating—Timolol—glaucoma	0.000141	0.000402	CcSEcCtD
Rabeprazole—Dizziness—Apraclonidine—glaucoma	0.000141	0.000402	CcSEcCtD
Rabeprazole—Malnutrition—Betaxolol—glaucoma	0.00014	0.000402	CcSEcCtD
Rabeprazole—Erythema—Betaxolol—glaucoma	0.00014	0.000402	CcSEcCtD
Rabeprazole—Urticaria—Dorzolamide—glaucoma	0.000138	0.000396	CcSEcCtD
Rabeprazole—Epistaxis—Timolol—glaucoma	0.000138	0.000396	CcSEcCtD
Rabeprazole—Body temperature increased—Dorzolamide—glaucoma	0.000138	0.000394	CcSEcCtD
Rabeprazole—Abdominal pain—Dorzolamide—glaucoma	0.000138	0.000394	CcSEcCtD
Rabeprazole—CYP3A4—Estrogen metabolism—CYP1B1—glaucoma	0.000138	0.00724	CbGpPWpGaD
Rabeprazole—Tension—Betaxolol—glaucoma	0.000138	0.000394	CcSEcCtD
Rabeprazole—Sinusitis—Timolol—glaucoma	0.000138	0.000394	CcSEcCtD
Rabeprazole—Dysgeusia—Betaxolol—glaucoma	0.000137	0.000393	CcSEcCtD
Rabeprazole—Arthralgia—Clonidine—glaucoma	0.000137	0.000393	CcSEcCtD
Rabeprazole—Chest pain—Clonidine—glaucoma	0.000137	0.000393	CcSEcCtD
Rabeprazole—Abdominal pain—Travoprost—glaucoma	0.000137	0.000393	CcSEcCtD
Rabeprazole—Agranulocytosis—Timolol—glaucoma	0.000137	0.000392	CcSEcCtD
Rabeprazole—Anxiety—Clonidine—glaucoma	0.000137	0.000391	CcSEcCtD
Rabeprazole—Asthenia—Acetazolamide—glaucoma	0.000136	0.000391	CcSEcCtD
Rabeprazole—Dizziness—Bimatoprost—glaucoma	0.000136	0.00039	CcSEcCtD
Rabeprazole—Nervousness—Betaxolol—glaucoma	0.000136	0.00039	CcSEcCtD
Rabeprazole—Urticaria—Brinzolamide—glaucoma	0.000136	0.00039	CcSEcCtD
Rabeprazole—Feeling abnormal—Pilocarpine—glaucoma	0.000136	0.000388	CcSEcCtD
Rabeprazole—Discomfort—Clonidine—glaucoma	0.000135	0.000388	CcSEcCtD
Rabeprazole—Vomiting—Apraclonidine—glaucoma	0.000135	0.000387	CcSEcCtD
Rabeprazole—Muscle spasms—Betaxolol—glaucoma	0.000135	0.000386	CcSEcCtD
Rabeprazole—Gastrointestinal pain—Pilocarpine—glaucoma	0.000135	0.000385	CcSEcCtD
Rabeprazole—Hypersensitivity—Brimonidine—glaucoma	0.000134	0.000385	CcSEcCtD
Rabeprazole—Dry mouth—Clonidine—glaucoma	0.000134	0.000384	CcSEcCtD
Rabeprazole—Bradycardia—Timolol—glaucoma	0.000134	0.000384	CcSEcCtD
Rabeprazole—Dermatitis—Apraclonidine—glaucoma	0.000134	0.000383	CcSEcCtD
Rabeprazole—Headache—Apraclonidine—glaucoma	0.000133	0.000381	CcSEcCtD
Rabeprazole—Confusional state—Clonidine—glaucoma	0.000133	0.00038	CcSEcCtD
Rabeprazole—Vision blurred—Betaxolol—glaucoma	0.000132	0.000378	CcSEcCtD
Rabeprazole—CYP1A1—Tryptophan metabolism—CYP1B1—glaucoma	0.000132	0.00695	CbGpPWpGaD
Rabeprazole—CYP1A1—Aryl Hydrocarbon Receptor—CYP1B1—glaucoma	0.000132	0.00695	CbGpPWpGaD
Rabeprazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—CYP1B1—glaucoma	0.000132	0.00695	CbGpPWpGaD
Rabeprazole—Rhinitis—Timolol—glaucoma	0.000132	0.000378	CcSEcCtD
Rabeprazole—Oedema—Clonidine—glaucoma	0.000131	0.000376	CcSEcCtD
Rabeprazole—Tremor—Betaxolol—glaucoma	0.000131	0.000376	CcSEcCtD
Rabeprazole—Asthenia—Brimonidine—glaucoma	0.000131	0.000375	CcSEcCtD
Rabeprazole—Body temperature increased—Pilocarpine—glaucoma	0.00013	0.000373	CcSEcCtD
Rabeprazole—Abdominal pain—Pilocarpine—glaucoma	0.00013	0.000373	CcSEcCtD
Rabeprazole—Ill-defined disorder—Betaxolol—glaucoma	0.00013	0.000373	CcSEcCtD
Rabeprazole—Diarrhoea—Acetazolamide—glaucoma	0.00013	0.000372	CcSEcCtD
Rabeprazole—Rash—Bimatoprost—glaucoma	0.00013	0.000372	CcSEcCtD
Rabeprazole—Dermatitis—Bimatoprost—glaucoma	0.00013	0.000372	CcSEcCtD
Rabeprazole—Oedema peripheral—Timolol—glaucoma	0.00013	0.000371	CcSEcCtD
Rabeprazole—Anaemia—Betaxolol—glaucoma	0.00013	0.000371	CcSEcCtD
Rabeprazole—Shock—Clonidine—glaucoma	0.000129	0.00037	CcSEcCtD
Rabeprazole—Pruritus—Brimonidine—glaucoma	0.000129	0.00037	CcSEcCtD
Rabeprazole—Headache—Bimatoprost—glaucoma	0.000129	0.00037	CcSEcCtD
Rabeprazole—Thrombocytopenia—Clonidine—glaucoma	0.000129	0.000369	CcSEcCtD
Rabeprazole—Hypersensitivity—Dorzolamide—glaucoma	0.000128	0.000368	CcSEcCtD
Rabeprazole—Tachycardia—Clonidine—glaucoma	0.000128	0.000367	CcSEcCtD
Rabeprazole—Hypersensitivity—Travoprost—glaucoma	0.000128	0.000366	CcSEcCtD
Rabeprazole—Hyperhidrosis—Clonidine—glaucoma	0.000127	0.000364	CcSEcCtD
Rabeprazole—Visual impairment—Timolol—glaucoma	0.000127	0.000363	CcSEcCtD
Rabeprazole—Malaise—Betaxolol—glaucoma	0.000126	0.000362	CcSEcCtD
Rabeprazole—CYP2C19—Melatonin metabolism and effects—EDN1—glaucoma	0.000126	0.00665	CbGpPWpGaD
Rabeprazole—Nausea—Apraclonidine—glaucoma	0.000126	0.000361	CcSEcCtD
Rabeprazole—Hypersensitivity—Brinzolamide—glaucoma	0.000126	0.000361	CcSEcCtD
Rabeprazole—Vertigo—Betaxolol—glaucoma	0.000126	0.000361	CcSEcCtD
Rabeprazole—Syncope—Betaxolol—glaucoma	0.000126	0.00036	CcSEcCtD
Rabeprazole—Dizziness—Acetazolamide—glaucoma	0.000126	0.00036	CcSEcCtD
Rabeprazole—CYP1A1—Melatonin metabolism and effects—APOE—glaucoma	0.000126	0.00661	CbGpPWpGaD
Rabeprazole—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.000126	0.0066	CbGpPWpGaD
Rabeprazole—Anorexia—Clonidine—glaucoma	0.000125	0.000359	CcSEcCtD
Rabeprazole—Asthenia—Dorzolamide—glaucoma	0.000125	0.000358	CcSEcCtD
Rabeprazole—Asthenia—Travoprost—glaucoma	0.000124	0.000356	CcSEcCtD
Rabeprazole—Palpitations—Betaxolol—glaucoma	0.000124	0.000355	CcSEcCtD
Rabeprazole—CYP1A1—Arachidonic acid metabolism—CYP1B1—glaucoma	0.000124	0.0065	CbGpPWpGaD
Rabeprazole—Pruritus—Dorzolamide—glaucoma	0.000123	0.000353	CcSEcCtD
Rabeprazole—Loss of consciousness—Betaxolol—glaucoma	0.000123	0.000353	CcSEcCtD
Rabeprazole—Eye disorder—Timolol—glaucoma	0.000123	0.000352	CcSEcCtD
Rabeprazole—Asthenia—Brinzolamide—glaucoma	0.000123	0.000352	CcSEcCtD
Rabeprazole—Hypotension—Clonidine—glaucoma	0.000123	0.000352	CcSEcCtD
Rabeprazole—Pruritus—Travoprost—glaucoma	0.000123	0.000351	CcSEcCtD
Rabeprazole—Tinnitus—Timolol—glaucoma	0.000123	0.000351	CcSEcCtD
Rabeprazole—Cough—Betaxolol—glaucoma	0.000122	0.00035	CcSEcCtD
Rabeprazole—Nausea—Bimatoprost—glaucoma	0.000122	0.00035	CcSEcCtD
Rabeprazole—CYP1A2—Melatonin metabolism and effects—CYP1B1—glaucoma	0.000122	0.00641	CbGpPWpGaD
Rabeprazole—CYP3A4—Tamoxifen metabolism—CYP1B1—glaucoma	0.000122	0.0064	CbGpPWpGaD
Rabeprazole—Hypersensitivity—Pilocarpine—glaucoma	0.000121	0.000347	CcSEcCtD
Rabeprazole—Pruritus—Brinzolamide—glaucoma	0.000121	0.000347	CcSEcCtD
Rabeprazole—Vomiting—Acetazolamide—glaucoma	0.000121	0.000346	CcSEcCtD
Rabeprazole—Dizziness—Brimonidine—glaucoma	0.000121	0.000345	CcSEcCtD
Rabeprazole—Musculoskeletal discomfort—Clonidine—glaucoma	0.00012	0.000343	CcSEcCtD
Rabeprazole—Angiopathy—Timolol—glaucoma	0.000119	0.000342	CcSEcCtD
Rabeprazole—Myalgia—Betaxolol—glaucoma	0.000119	0.000342	CcSEcCtD
Rabeprazole—Arthralgia—Betaxolol—glaucoma	0.000119	0.000342	CcSEcCtD
Rabeprazole—Chest pain—Betaxolol—glaucoma	0.000119	0.000342	CcSEcCtD
Rabeprazole—Diarrhoea—Dorzolamide—glaucoma	0.000119	0.000341	CcSEcCtD
Rabeprazole—Headache—Acetazolamide—glaucoma	0.000119	0.000341	CcSEcCtD
Rabeprazole—Anxiety—Betaxolol—glaucoma	0.000119	0.000341	CcSEcCtD
Rabeprazole—Insomnia—Clonidine—glaucoma	0.000119	0.00034	CcSEcCtD
Rabeprazole—Diarrhoea—Travoprost—glaucoma	0.000119	0.00034	CcSEcCtD
Rabeprazole—ABCG2—HIF-1-alpha transcription factor network—EDN1—glaucoma	0.000118	0.00622	CbGpPWpGaD
Rabeprazole—Asthenia—Pilocarpine—glaucoma	0.000118	0.000338	CcSEcCtD
Rabeprazole—Paraesthesia—Clonidine—glaucoma	0.000118	0.000338	CcSEcCtD
Rabeprazole—Discomfort—Betaxolol—glaucoma	0.000118	0.000338	CcSEcCtD
Rabeprazole—Arrhythmia—Timolol—glaucoma	0.000118	0.000337	CcSEcCtD
Rabeprazole—Dyspnoea—Clonidine—glaucoma	0.000117	0.000336	CcSEcCtD
Rabeprazole—Diarrhoea—Brinzolamide—glaucoma	0.000117	0.000336	CcSEcCtD
Rabeprazole—Somnolence—Clonidine—glaucoma	0.000117	0.000335	CcSEcCtD
Rabeprazole—Dry mouth—Betaxolol—glaucoma	0.000117	0.000334	CcSEcCtD
Rabeprazole—Pruritus—Pilocarpine—glaucoma	0.000116	0.000334	CcSEcCtD
Rabeprazole—CYP2D6—Melatonin metabolism and effects—EDN1—glaucoma	0.000116	0.00612	CbGpPWpGaD
Rabeprazole—Alopecia—Timolol—glaucoma	0.000116	0.000333	CcSEcCtD
Rabeprazole—Confusional state—Betaxolol—glaucoma	0.000115	0.00033	CcSEcCtD
Rabeprazole—Dizziness—Dorzolamide—glaucoma	0.000115	0.00033	CcSEcCtD
Rabeprazole—Rash—Brimonidine—glaucoma	0.000115	0.000329	CcSEcCtD
Rabeprazole—Dermatitis—Brimonidine—glaucoma	0.000115	0.000329	CcSEcCtD
Rabeprazole—Dizziness—Travoprost—glaucoma	0.000115	0.000328	CcSEcCtD
Rabeprazole—Erythema—Timolol—glaucoma	0.000115	0.000328	CcSEcCtD
Rabeprazole—Malnutrition—Timolol—glaucoma	0.000115	0.000328	CcSEcCtD
Rabeprazole—Oedema—Betaxolol—glaucoma	0.000114	0.000328	CcSEcCtD
Rabeprazole—Headache—Brimonidine—glaucoma	0.000114	0.000327	CcSEcCtD
Rabeprazole—Decreased appetite—Clonidine—glaucoma	0.000114	0.000327	CcSEcCtD
Rabeprazole—Dizziness—Brinzolamide—glaucoma	0.000113	0.000324	CcSEcCtD
Rabeprazole—Nausea—Acetazolamide—glaucoma	0.000113	0.000323	CcSEcCtD
Rabeprazole—Diarrhoea—Pilocarpine—glaucoma	0.000113	0.000323	CcSEcCtD
Rabeprazole—Shock—Betaxolol—glaucoma	0.000113	0.000322	CcSEcCtD
Rabeprazole—Tension—Timolol—glaucoma	0.000112	0.000322	CcSEcCtD
Rabeprazole—Pain—Clonidine—glaucoma	0.000112	0.000322	CcSEcCtD
Rabeprazole—Constipation—Clonidine—glaucoma	0.000112	0.000322	CcSEcCtD
Rabeprazole—Dysgeusia—Timolol—glaucoma	0.000112	0.000321	CcSEcCtD
Rabeprazole—Thrombocytopenia—Betaxolol—glaucoma	0.000112	0.000321	CcSEcCtD
Rabeprazole—Tachycardia—Betaxolol—glaucoma	0.000112	0.00032	CcSEcCtD
Rabeprazole—Nervousness—Timolol—glaucoma	0.000111	0.000319	CcSEcCtD
Rabeprazole—Vomiting—Dorzolamide—glaucoma	0.000111	0.000317	CcSEcCtD
Rabeprazole—Hyperhidrosis—Betaxolol—glaucoma	0.000111	0.000317	CcSEcCtD
Rabeprazole—CYP3A4—Estrogen metabolism—GSTM1—glaucoma	0.00011	0.00579	CbGpPWpGaD
Rabeprazole—Rash—Dorzolamide—glaucoma	0.00011	0.000315	CcSEcCtD
Rabeprazole—Dermatitis—Dorzolamide—glaucoma	0.00011	0.000314	CcSEcCtD
Rabeprazole—Rash—Travoprost—glaucoma	0.000109	0.000313	CcSEcCtD
Rabeprazole—Dermatitis—Travoprost—glaucoma	0.000109	0.000313	CcSEcCtD
Rabeprazole—Headache—Dorzolamide—glaucoma	0.000109	0.000313	CcSEcCtD
Rabeprazole—Anorexia—Betaxolol—glaucoma	0.000109	0.000312	CcSEcCtD
Rabeprazole—Vomiting—Brinzolamide—glaucoma	0.000109	0.000312	CcSEcCtD
Rabeprazole—Dizziness—Pilocarpine—glaucoma	0.000109	0.000312	CcSEcCtD
Rabeprazole—Headache—Travoprost—glaucoma	0.000109	0.000311	CcSEcCtD
Rabeprazole—ABCG2—Transmembrane transport of small molecules—PEX19—glaucoma	0.000108	0.00571	CbGpPWpGaD
Rabeprazole—Nausea—Brimonidine—glaucoma	0.000108	0.00031	CcSEcCtD
Rabeprazole—Feeling abnormal—Clonidine—glaucoma	0.000108	0.00031	CcSEcCtD
Rabeprazole—Rash—Brinzolamide—glaucoma	0.000108	0.000309	CcSEcCtD
Rabeprazole—Vision blurred—Timolol—glaucoma	0.000108	0.000309	CcSEcCtD
Rabeprazole—Dermatitis—Brinzolamide—glaucoma	0.000108	0.000309	CcSEcCtD
Rabeprazole—Gastrointestinal pain—Clonidine—glaucoma	0.000107	0.000308	CcSEcCtD
Rabeprazole—Headache—Brinzolamide—glaucoma	0.000107	0.000307	CcSEcCtD
Rabeprazole—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.000107	0.00564	CbGpPWpGaD
Rabeprazole—Hypotension—Betaxolol—glaucoma	0.000107	0.000306	CcSEcCtD
Rabeprazole—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000107	0.00562	CbGpPWpGaD
Rabeprazole—CYP1A1—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.000105	0.00554	CbGpPWpGaD
Rabeprazole—Angioedema—Timolol—glaucoma	0.000105	0.0003	CcSEcCtD
Rabeprazole—Vomiting—Pilocarpine—glaucoma	0.000105	0.0003	CcSEcCtD
Rabeprazole—Urticaria—Clonidine—glaucoma	0.000104	0.000299	CcSEcCtD
Rabeprazole—Musculoskeletal discomfort—Betaxolol—glaucoma	0.000104	0.000299	CcSEcCtD
Rabeprazole—Abdominal pain—Clonidine—glaucoma	0.000104	0.000298	CcSEcCtD
Rabeprazole—Body temperature increased—Clonidine—glaucoma	0.000104	0.000298	CcSEcCtD
Rabeprazole—Rash—Pilocarpine—glaucoma	0.000104	0.000297	CcSEcCtD
Rabeprazole—Dermatitis—Pilocarpine—glaucoma	0.000104	0.000297	CcSEcCtD
Rabeprazole—Insomnia—Betaxolol—glaucoma	0.000104	0.000296	CcSEcCtD
Rabeprazole—Nausea—Dorzolamide—glaucoma	0.000103	0.000296	CcSEcCtD
Rabeprazole—Headache—Pilocarpine—glaucoma	0.000103	0.000295	CcSEcCtD
Rabeprazole—Nausea—Travoprost—glaucoma	0.000103	0.000295	CcSEcCtD
Rabeprazole—Vertigo—Timolol—glaucoma	0.000103	0.000295	CcSEcCtD
Rabeprazole—CYP2C19—Melatonin metabolism and effects—APOE—glaucoma	0.000103	0.00541	CbGpPWpGaD
Rabeprazole—Paraesthesia—Betaxolol—glaucoma	0.000103	0.000294	CcSEcCtD
Rabeprazole—Syncope—Timolol—glaucoma	0.000103	0.000294	CcSEcCtD
Rabeprazole—Dyspnoea—Betaxolol—glaucoma	0.000102	0.000292	CcSEcCtD
Rabeprazole—Nausea—Brinzolamide—glaucoma	0.000102	0.000291	CcSEcCtD
Rabeprazole—Palpitations—Timolol—glaucoma	0.000101	0.00029	CcSEcCtD
Rabeprazole—CYP2C19—Arachidonic acid metabolism—CYP1B1—glaucoma	0.000101	0.00532	CbGpPWpGaD
Rabeprazole—Dyspepsia—Betaxolol—glaucoma	0.000101	0.000289	CcSEcCtD
Rabeprazole—Loss of consciousness—Timolol—glaucoma	0.000101	0.000288	CcSEcCtD
Rabeprazole—Cough—Timolol—glaucoma	0.0001	0.000286	CcSEcCtD
Rabeprazole—Decreased appetite—Betaxolol—glaucoma	9.95e-05	0.000285	CcSEcCtD
Rabeprazole—Hypertension—Timolol—glaucoma	9.89e-05	0.000283	CcSEcCtD
Rabeprazole—CYP1A2—Melatonin metabolism and effects—EDN1—glaucoma	9.85e-05	0.00518	CbGpPWpGaD
Rabeprazole—Constipation—Betaxolol—glaucoma	9.79e-05	0.00028	CcSEcCtD
Rabeprazole—Pain—Betaxolol—glaucoma	9.79e-05	0.00028	CcSEcCtD
Rabeprazole—Nausea—Pilocarpine—glaucoma	9.78e-05	0.00028	CcSEcCtD
Rabeprazole—Chest pain—Timolol—glaucoma	9.75e-05	0.000279	CcSEcCtD
Rabeprazole—Arthralgia—Timolol—glaucoma	9.75e-05	0.000279	CcSEcCtD
Rabeprazole—Myalgia—Timolol—glaucoma	9.75e-05	0.000279	CcSEcCtD
Rabeprazole—Anxiety—Timolol—glaucoma	9.72e-05	0.000278	CcSEcCtD
Rabeprazole—Hypersensitivity—Clonidine—glaucoma	9.69e-05	0.000277	CcSEcCtD
Rabeprazole—Discomfort—Timolol—glaucoma	9.64e-05	0.000276	CcSEcCtD
Rabeprazole—Dry mouth—Timolol—glaucoma	9.54e-05	0.000273	CcSEcCtD
Rabeprazole—CYP2D6—Melatonin metabolism and effects—APOE—glaucoma	9.46e-05	0.00497	CbGpPWpGaD
Rabeprazole—Asthenia—Clonidine—glaucoma	9.43e-05	0.00027	CcSEcCtD
Rabeprazole—Feeling abnormal—Betaxolol—glaucoma	9.43e-05	0.00027	CcSEcCtD
Rabeprazole—Confusional state—Timolol—glaucoma	9.43e-05	0.00027	CcSEcCtD
Rabeprazole—Oedema—Timolol—glaucoma	9.35e-05	0.000268	CcSEcCtD
Rabeprazole—Anaphylactic shock—Timolol—glaucoma	9.35e-05	0.000268	CcSEcCtD
Rabeprazole—Pruritus—Clonidine—glaucoma	9.3e-05	0.000266	CcSEcCtD
Rabeprazole—CYP2C9—Arachidonic acid metabolism—CYP1B1—glaucoma	9.22e-05	0.00485	CbGpPWpGaD
Rabeprazole—Shock—Timolol—glaucoma	9.2e-05	0.000263	CcSEcCtD
Rabeprazole—Urticaria—Betaxolol—glaucoma	9.09e-05	0.00026	CcSEcCtD
Rabeprazole—Body temperature increased—Betaxolol—glaucoma	9.05e-05	0.000259	CcSEcCtD
Rabeprazole—Hyperhidrosis—Timolol—glaucoma	9.04e-05	0.000259	CcSEcCtD
Rabeprazole—Diarrhoea—Clonidine—glaucoma	8.99e-05	0.000258	CcSEcCtD
Rabeprazole—Anorexia—Timolol—glaucoma	8.91e-05	0.000255	CcSEcCtD
Rabeprazole—ABCG2—HIF-2-alpha transcription factor network—VEGFA—glaucoma	8.82e-05	0.00464	CbGpPWpGaD
Rabeprazole—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	8.74e-05	0.0046	CbGpPWpGaD
Rabeprazole—Hypotension—Timolol—glaucoma	8.74e-05	0.00025	CcSEcCtD
Rabeprazole—Dizziness—Clonidine—glaucoma	8.69e-05	0.000249	CcSEcCtD
Rabeprazole—CYP1A1—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	8.66e-05	0.00455	CbGpPWpGaD
Rabeprazole—CYP2C19—Oxidation by Cytochrome P450—CYP1B1—glaucoma	8.62e-05	0.00454	CbGpPWpGaD
Rabeprazole—Musculoskeletal discomfort—Timolol—glaucoma	8.52e-05	0.000244	CcSEcCtD
Rabeprazole—Insomnia—Timolol—glaucoma	8.46e-05	0.000242	CcSEcCtD
Rabeprazole—Hypersensitivity—Betaxolol—glaucoma	8.43e-05	0.000241	CcSEcCtD
Rabeprazole—CYP1A2—Tryptophan metabolism—CYP1B1—glaucoma	8.42e-05	0.00443	CbGpPWpGaD
Rabeprazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1B1—glaucoma	8.42e-05	0.00443	CbGpPWpGaD
Rabeprazole—CYP1A2—Aryl Hydrocarbon Receptor—CYP1B1—glaucoma	8.42e-05	0.00443	CbGpPWpGaD
Rabeprazole—Paraesthesia—Timolol—glaucoma	8.4e-05	0.00024	CcSEcCtD
Rabeprazole—Vomiting—Clonidine—glaucoma	8.36e-05	0.000239	CcSEcCtD
Rabeprazole—Dyspnoea—Timolol—glaucoma	8.34e-05	0.000239	CcSEcCtD
Rabeprazole—Somnolence—Timolol—glaucoma	8.31e-05	0.000238	CcSEcCtD
Rabeprazole—Rash—Clonidine—glaucoma	8.29e-05	0.000237	CcSEcCtD
Rabeprazole—Dermatitis—Clonidine—glaucoma	8.28e-05	0.000237	CcSEcCtD
Rabeprazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	8.28e-05	0.00435	CbGpPWpGaD
Rabeprazole—Headache—Clonidine—glaucoma	8.24e-05	0.000236	CcSEcCtD
Rabeprazole—Dyspepsia—Timolol—glaucoma	8.23e-05	0.000236	CcSEcCtD
Rabeprazole—Asthenia—Betaxolol—glaucoma	8.21e-05	0.000235	CcSEcCtD
Rabeprazole—Decreased appetite—Timolol—glaucoma	8.13e-05	0.000233	CcSEcCtD
Rabeprazole—Pruritus—Betaxolol—glaucoma	8.1e-05	0.000232	CcSEcCtD
Rabeprazole—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	8.04e-05	0.00423	CbGpPWpGaD
Rabeprazole—CYP1A2—Melatonin metabolism and effects—APOE—glaucoma	8.01e-05	0.00421	CbGpPWpGaD
Rabeprazole—Pain—Timolol—glaucoma	8e-05	0.000229	CcSEcCtD
Rabeprazole—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	7.97e-05	0.00419	CbGpPWpGaD
Rabeprazole—CYP2D6—Oxidation by Cytochrome P450—CYP1B1—glaucoma	7.93e-05	0.00417	CbGpPWpGaD
Rabeprazole—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—glaucoma	7.92e-05	0.00417	CbGpPWpGaD
Rabeprazole—CYP1A2—Arachidonic acid metabolism—CYP1B1—glaucoma	7.88e-05	0.00414	CbGpPWpGaD
Rabeprazole—CYP2C9—Oxidation by Cytochrome P450—CYP1B1—glaucoma	7.86e-05	0.00414	CbGpPWpGaD
Rabeprazole—Diarrhoea—Betaxolol—glaucoma	7.83e-05	0.000224	CcSEcCtD
Rabeprazole—Nausea—Clonidine—glaucoma	7.81e-05	0.000224	CcSEcCtD
Rabeprazole—Feeling abnormal—Timolol—glaucoma	7.7e-05	0.000221	CcSEcCtD
Rabeprazole—Gastrointestinal pain—Timolol—glaucoma	7.65e-05	0.000219	CcSEcCtD
Rabeprazole—Dizziness—Betaxolol—glaucoma	7.57e-05	0.000217	CcSEcCtD
Rabeprazole—Urticaria—Timolol—glaucoma	7.43e-05	0.000213	CcSEcCtD
Rabeprazole—Body temperature increased—Timolol—glaucoma	7.39e-05	0.000212	CcSEcCtD
Rabeprazole—Abdominal pain—Timolol—glaucoma	7.39e-05	0.000212	CcSEcCtD
Rabeprazole—ABCG2—Transmembrane transport of small molecules—SLC4A4—glaucoma	7.33e-05	0.00385	CbGpPWpGaD
Rabeprazole—Vomiting—Betaxolol—glaucoma	7.28e-05	0.000208	CcSEcCtD
Rabeprazole—Rash—Betaxolol—glaucoma	7.22e-05	0.000207	CcSEcCtD
Rabeprazole—Dermatitis—Betaxolol—glaucoma	7.21e-05	0.000206	CcSEcCtD
Rabeprazole—Headache—Betaxolol—glaucoma	7.17e-05	0.000205	CcSEcCtD
Rabeprazole—CYP2C19—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	7.08e-05	0.00373	CbGpPWpGaD
Rabeprazole—Hypersensitivity—Timolol—glaucoma	6.89e-05	0.000197	CcSEcCtD
Rabeprazole—ABCG2—Fluoropyrimidine Activity—TP53—glaucoma	6.83e-05	0.00359	CbGpPWpGaD
Rabeprazole—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	6.81e-05	0.00358	CbGpPWpGaD
Rabeprazole—Nausea—Betaxolol—glaucoma	6.8e-05	0.000195	CcSEcCtD
Rabeprazole—CYP1A2—Oxidation by Cytochrome P450—CYP1B1—glaucoma	6.72e-05	0.00353	CbGpPWpGaD
Rabeprazole—Asthenia—Timolol—glaucoma	6.71e-05	0.000192	CcSEcCtD
Rabeprazole—Pruritus—Timolol—glaucoma	6.61e-05	0.000189	CcSEcCtD
Rabeprazole—CYP1A1—PPARA activates gene expression—ABCA1—glaucoma	6.58e-05	0.00346	CbGpPWpGaD
Rabeprazole—CYP2D6—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	6.52e-05	0.00343	CbGpPWpGaD
Rabeprazole—CYP3A4—Tryptophan metabolism—CYP1B1—glaucoma	6.5e-05	0.00342	CbGpPWpGaD
Rabeprazole—CYP2C9—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	6.46e-05	0.0034	CbGpPWpGaD
Rabeprazole—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—ABCA1—glaucoma	6.44e-05	0.00338	CbGpPWpGaD
Rabeprazole—Diarrhoea—Timolol—glaucoma	6.4e-05	0.000183	CcSEcCtD
Rabeprazole—CYP1A2—Phase II conjugation—GSTT1—glaucoma	6.29e-05	0.00331	CbGpPWpGaD
Rabeprazole—Dizziness—Timolol—glaucoma	6.18e-05	0.000177	CcSEcCtD
Rabeprazole—ABCG2—Metabolism—CA5A—glaucoma	5.98e-05	0.00314	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—NARFL—glaucoma	5.98e-05	0.00314	CbGpPWpGaD
Rabeprazole—CYP1A1—Aryl Hydrocarbon Receptor—PTGS2—glaucoma	5.95e-05	0.00313	CbGpPWpGaD
Rabeprazole—Vomiting—Timolol—glaucoma	5.94e-05	0.00017	CcSEcCtD
Rabeprazole—Rash—Timolol—glaucoma	5.9e-05	0.000169	CcSEcCtD
Rabeprazole—Dermatitis—Timolol—glaucoma	5.89e-05	0.000169	CcSEcCtD
Rabeprazole—Headache—Timolol—glaucoma	5.86e-05	0.000168	CcSEcCtD
Rabeprazole—CYP1A1—Biological oxidations—GSTT1—glaucoma	5.77e-05	0.00304	CbGpPWpGaD
Rabeprazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—CDKN1B—glaucoma	5.64e-05	0.00297	CbGpPWpGaD
Rabeprazole—CYP1A1—Aryl Hydrocarbon Receptor—CDKN1B—glaucoma	5.64e-05	0.00297	CbGpPWpGaD
Rabeprazole—CYP1A1—Arachidonic acid metabolism—PTGS2—glaucoma	5.57e-05	0.00293	CbGpPWpGaD
Rabeprazole—Nausea—Timolol—glaucoma	5.55e-05	0.000159	CcSEcCtD
Rabeprazole—CYP1A2—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	5.52e-05	0.0029	CbGpPWpGaD
Rabeprazole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	5.26e-05	0.00276	CbGpPWpGaD
Rabeprazole—ABCG2—HIF-1-alpha transcription factor network—VEGFA—glaucoma	5.19e-05	0.00273	CbGpPWpGaD
Rabeprazole—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—glaucoma	5.19e-05	0.00273	CbGpPWpGaD
Rabeprazole—ABCG2—Transmembrane transport of small molecules—SLC6A13—glaucoma	4.89e-05	0.00257	CbGpPWpGaD
Rabeprazole—CYP2C19—Biological oxidations—GSTT1—glaucoma	4.72e-05	0.00248	CbGpPWpGaD
Rabeprazole—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—glaucoma	4.69e-05	0.00247	CbGpPWpGaD
Rabeprazole—CYP1A1—Biological oxidations—CYP1B1—glaucoma	4.6e-05	0.00242	CbGpPWpGaD
Rabeprazole—CYP2C19—Arachidonic acid metabolism—PTGS2—glaucoma	4.56e-05	0.0024	CbGpPWpGaD
Rabeprazole—CYP1A1—Metapathway biotransformation—CYP1B1—glaucoma	4.54e-05	0.00239	CbGpPWpGaD
Rabeprazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—ABCA1—glaucoma	4.43e-05	0.00233	CbGpPWpGaD
Rabeprazole—CYP2D6—Biological oxidations—GSTT1—glaucoma	4.34e-05	0.00228	CbGpPWpGaD
Rabeprazole—CYP2C9—Biological oxidations—GSTT1—glaucoma	4.31e-05	0.00227	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism of lipids and lipoproteins—CTSA—glaucoma	4.3e-05	0.00226	CbGpPWpGaD
Rabeprazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	4.26e-05	0.00224	CbGpPWpGaD
Rabeprazole—CYP2C9—Arachidonic acid metabolism—PTGS2—glaucoma	4.16e-05	0.00219	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—CA5A—glaucoma	4.05e-05	0.00213	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—NARFL—glaucoma	4.05e-05	0.00213	CbGpPWpGaD
Rabeprazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—glaucoma	4.02e-05	0.00211	CbGpPWpGaD
Rabeprazole—CYP1A1—Aryl Hydrocarbon Receptor—TNF—glaucoma	4.02e-05	0.00211	CbGpPWpGaD
Rabeprazole—CYP1A2—Phase II conjugation—GSTM1—glaucoma	4.01e-05	0.00211	CbGpPWpGaD
Rabeprazole—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—glaucoma	3.8e-05	0.002	CbGpPWpGaD
Rabeprazole—CYP2C19—Biological oxidations—CYP1B1—glaucoma	3.76e-05	0.00198	CbGpPWpGaD
Rabeprazole—CYP2C19—Metapathway biotransformation—CYP1B1—glaucoma	3.71e-05	0.00195	CbGpPWpGaD
Rabeprazole—CYP1A2—Biological oxidations—GSTT1—glaucoma	3.68e-05	0.00194	CbGpPWpGaD
Rabeprazole—CYP1A1—Biological oxidations—GSTM1—glaucoma	3.68e-05	0.00193	CbGpPWpGaD
Rabeprazole—CYP1A1—Metapathway biotransformation—GSTM1—glaucoma	3.63e-05	0.00191	CbGpPWpGaD
Rabeprazole—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—glaucoma	3.6e-05	0.00189	CbGpPWpGaD
Rabeprazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—glaucoma	3.6e-05	0.00189	CbGpPWpGaD
Rabeprazole—ABCG2—Transmembrane transport of small molecules—SLC6A1—glaucoma	3.58e-05	0.00188	CbGpPWpGaD
Rabeprazole—CYP1A2—Arachidonic acid metabolism—PTGS2—glaucoma	3.55e-05	0.00187	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism of lipids and lipoproteins—CTSA—glaucoma	3.52e-05	0.00185	CbGpPWpGaD
Rabeprazole—CYP2D6—Biological oxidations—CYP1B1—glaucoma	3.46e-05	0.00182	CbGpPWpGaD
Rabeprazole—CYP2C9—Biological oxidations—CYP1B1—glaucoma	3.43e-05	0.0018	CbGpPWpGaD
Rabeprazole—CYP2D6—Metapathway biotransformation—CYP1B1—glaucoma	3.41e-05	0.0018	CbGpPWpGaD
Rabeprazole—CYP2C9—Metapathway biotransformation—CYP1B1—glaucoma	3.38e-05	0.00178	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—CA5A—glaucoma	3.31e-05	0.00174	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—NARFL—glaucoma	3.31e-05	0.00174	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—CTSA—glaucoma	3.21e-05	0.00169	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—NARFL—glaucoma	3.04e-05	0.0016	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—CA5A—glaucoma	3.04e-05	0.0016	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—NARFL—glaucoma	3.02e-05	0.00159	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—CA5A—glaucoma	3.02e-05	0.00159	CbGpPWpGaD
Rabeprazole—CYP2C19—Biological oxidations—GSTM1—glaucoma	3.01e-05	0.00158	CbGpPWpGaD
Rabeprazole—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—glaucoma	2.99e-05	0.00157	CbGpPWpGaD
Rabeprazole—CYP2C19—Metapathway biotransformation—GSTM1—glaucoma	2.97e-05	0.00156	CbGpPWpGaD
Rabeprazole—CYP1A2—Biological oxidations—CYP1B1—glaucoma	2.93e-05	0.00154	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—CA1—glaucoma	2.92e-05	0.00153	CbGpPWpGaD
Rabeprazole—CYP1A2—Metapathway biotransformation—CYP1B1—glaucoma	2.89e-05	0.00152	CbGpPWpGaD
Rabeprazole—CYP3A4—Biological oxidations—GSTT1—glaucoma	2.84e-05	0.00149	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—CTSA—glaucoma	2.83e-05	0.00149	CbGpPWpGaD
Rabeprazole—CYP2D6—Biological oxidations—GSTM1—glaucoma	2.77e-05	0.00146	CbGpPWpGaD
Rabeprazole—CYP2C9—Biological oxidations—GSTM1—glaucoma	2.74e-05	0.00144	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—CTSA—glaucoma	2.74e-05	0.00144	CbGpPWpGaD
Rabeprazole—CYP2D6—Metapathway biotransformation—GSTM1—glaucoma	2.73e-05	0.00144	CbGpPWpGaD
Rabeprazole—CYP2C9—Metapathway biotransformation—GSTM1—glaucoma	2.71e-05	0.00142	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—CA2—glaucoma	2.67e-05	0.0014	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—CA5A—glaucoma	2.58e-05	0.00136	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—NARFL—glaucoma	2.58e-05	0.00136	CbGpPWpGaD
Rabeprazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—glaucoma	2.56e-05	0.00135	CbGpPWpGaD
Rabeprazole—CYP1A2—Aryl Hydrocarbon Receptor—TNF—glaucoma	2.56e-05	0.00135	CbGpPWpGaD
Rabeprazole—CYP1A2—Biological oxidations—GSTM1—glaucoma	2.34e-05	0.00123	CbGpPWpGaD
Rabeprazole—CYP1A2—Metapathway biotransformation—GSTM1—glaucoma	2.31e-05	0.00122	CbGpPWpGaD
Rabeprazole—CYP3A4—Biological oxidations—CYP1B1—glaucoma	2.26e-05	0.00119	CbGpPWpGaD
Rabeprazole—CYP3A4—Metapathway biotransformation—CYP1B1—glaucoma	2.23e-05	0.00117	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—CA5A—glaucoma	1.99e-05	0.00105	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—NARFL—glaucoma	1.99e-05	0.00105	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—CA1—glaucoma	1.98e-05	0.00104	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—CTSA—glaucoma	1.91e-05	0.00101	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—TXN—glaucoma	1.88e-05	0.000989	CbGpPWpGaD
Rabeprazole—CYP3A4—Biological oxidations—GSTM1—glaucoma	1.81e-05	0.000952	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—CA2—glaucoma	1.81e-05	0.00095	CbGpPWpGaD
Rabeprazole—CYP3A4—Metapathway biotransformation—GSTM1—glaucoma	1.78e-05	0.000938	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	1.77e-05	0.000929	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	1.77e-05	0.000929	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—CA1—glaucoma	1.62e-05	0.00085	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—CTSA—glaucoma	1.57e-05	0.000823	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—CA1—glaucoma	1.49e-05	0.000782	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—CA2—glaucoma	1.48e-05	0.000778	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—CA1—glaucoma	1.47e-05	0.000775	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—GSTT1—glaucoma	1.46e-05	0.000767	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	1.45e-05	0.00076	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	1.45e-05	0.00076	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—CTSA—glaucoma	1.44e-05	0.000757	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—CTSA—glaucoma	1.43e-05	0.000751	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—CA2—glaucoma	1.36e-05	0.000715	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—CA2—glaucoma	1.35e-05	0.000709	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	1.32e-05	0.000693	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	1.32e-05	0.000693	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—TXN—glaucoma	1.27e-05	0.00067	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—CA1—glaucoma	1.26e-05	0.000663	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—CTSA—glaucoma	1.22e-05	0.000642	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—ABCA1—glaucoma	1.16e-05	0.000611	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—CYP1B1—glaucoma	1.16e-05	0.000611	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism of lipids and lipoproteins—APOE—glaucoma	1.16e-05	0.000611	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—CA2—glaucoma	1.15e-05	0.000606	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism of lipids and lipoproteins—CAV1—glaucoma	1.15e-05	0.000605	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	1.13e-05	0.000592	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	1.13e-05	0.000592	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—TXN—glaucoma	1.04e-05	0.000548	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—GSTT1—glaucoma	9.87e-06	0.000519	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—CA1—glaucoma	9.72e-06	0.000511	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—TXN—glaucoma	9.58e-06	0.000504	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism of lipids and lipoproteins—APOE—glaucoma	9.51e-06	0.0005	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—TXN—glaucoma	9.5e-06	0.0005	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—glaucoma	9.42e-06	0.000495	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—CTSA—glaucoma	9.42e-06	0.000495	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—GSTM1—glaucoma	9.29e-06	0.000489	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—CA2—glaucoma	8.89e-06	0.000468	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—APOE—glaucoma	8.67e-06	0.000456	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—glaucoma	8.59e-06	0.000452	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—MTHFR—glaucoma	8.21e-06	0.000432	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—TXN—glaucoma	8.12e-06	0.000427	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—GSTT1—glaucoma	8.08e-06	0.000425	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	7.96e-06	0.000419	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—CYP1B1—glaucoma	7.86e-06	0.000414	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—ABCA1—glaucoma	7.86e-06	0.000414	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—APOE—glaucoma	7.64e-06	0.000402	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—CAV1—glaucoma	7.57e-06	0.000398	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—GSTT1—glaucoma	7.43e-06	0.000391	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—APOE—glaucoma	7.41e-06	0.00039	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—GSTT1—glaucoma	7.37e-06	0.000387	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—glaucoma	7.34e-06	0.000386	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	6.51e-06	0.000343	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—ABCA1—glaucoma	6.44e-06	0.000338	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—CYP1B1—glaucoma	6.44e-06	0.000338	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—GSTT1—glaucoma	6.29e-06	0.000331	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—GSTM1—glaucoma	6.29e-06	0.000331	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—TXN—glaucoma	6.26e-06	0.000329	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	5.94e-06	0.000312	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—CYP1B1—glaucoma	5.92e-06	0.000311	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—ABCA1—glaucoma	5.92e-06	0.000311	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—ABCA1—glaucoma	5.87e-06	0.000309	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—CYP1B1—glaucoma	5.87e-06	0.000309	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—NOS3—glaucoma	5.73e-06	0.000301	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—MTHFR—glaucoma	5.56e-06	0.000292	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—PTGS2—glaucoma	5.24e-06	0.000275	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—APOE—glaucoma	5.17e-06	0.000272	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—GSTM1—glaucoma	5.15e-06	0.000271	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—CAV1—glaucoma	5.13e-06	0.00027	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	5.07e-06	0.000267	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—ABCA1—glaucoma	5.01e-06	0.000264	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—CYP1B1—glaucoma	5.01e-06	0.000264	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—GSTT1—glaucoma	4.86e-06	0.000255	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—GSTM1—glaucoma	4.73e-06	0.000249	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—GSTM1—glaucoma	4.69e-06	0.000247	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—MTHFR—glaucoma	4.55e-06	0.000239	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—APOE—glaucoma	4.23e-06	0.000223	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—CAV1—glaucoma	4.19e-06	0.000221	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—MTHFR—glaucoma	4.18e-06	0.00022	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—MTHFR—glaucoma	4.15e-06	0.000218	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—GSTM1—glaucoma	4.01e-06	0.000211	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—APOE—glaucoma	3.89e-06	0.000205	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—NOS3—glaucoma	3.88e-06	0.000204	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—ABCA1—glaucoma	3.87e-06	0.000204	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—CYP1B1—glaucoma	3.87e-06	0.000204	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—APOE—glaucoma	3.86e-06	0.000203	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—CAV1—glaucoma	3.86e-06	0.000203	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—CAV1—glaucoma	3.82e-06	0.000201	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—PTGS2—glaucoma	3.54e-06	0.000186	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—MTHFR—glaucoma	3.54e-06	0.000186	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—APOE—glaucoma	3.3e-06	0.000173	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—CAV1—glaucoma	3.27e-06	0.000172	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—NOS3—glaucoma	3.17e-06	0.000167	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—GSTM1—glaucoma	3.09e-06	0.000163	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—NOS3—glaucoma	2.92e-06	0.000153	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—PTGS2—glaucoma	2.9e-06	0.000153	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—NOS3—glaucoma	2.89e-06	0.000152	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—MTHFR—glaucoma	2.73e-06	0.000144	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—PTGS2—glaucoma	2.67e-06	0.00014	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—PTGS2—glaucoma	2.64e-06	0.000139	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—APOE—glaucoma	2.55e-06	0.000134	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—CAV1—glaucoma	2.52e-06	0.000133	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—NOS3—glaucoma	2.47e-06	0.00013	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—PTGS2—glaucoma	2.26e-06	0.000119	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—NOS3—glaucoma	1.91e-06	0.0001	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—PTGS2—glaucoma	1.74e-06	9.17e-05	CbGpPWpGaD
